Clinical Trial

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Trial Details
NCT Number NCT03647072
Lead Sponsor Sherief Abd-Elsalam
Conditions Lymphoma
Enrollment 60 participants
Start Date 2018-08-01
Primary Completion 2027-10 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2018-08-27